DK0771217T3 - Faste lægemiddelformer, som indeholder clathrater af det steroide könshormon ethinylestadiol - Google Patents

Faste lægemiddelformer, som indeholder clathrater af det steroide könshormon ethinylestadiol

Info

Publication number
DK0771217T3
DK0771217T3 DK95943492T DK95943492T DK0771217T3 DK 0771217 T3 DK0771217 T3 DK 0771217T3 DK 95943492 T DK95943492 T DK 95943492T DK 95943492 T DK95943492 T DK 95943492T DK 0771217 T3 DK0771217 T3 DK 0771217T3
Authority
DK
Denmark
Prior art keywords
estadiol
solid pharmaceutical
pharmaceutical forms
forms containing
sex hormone
Prior art date
Application number
DK95943492T
Other languages
English (en)
Inventor
Johannes Tack
Thomas Backensfeld
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6524338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0771217(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0771217T3 publication Critical patent/DK0771217T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
DK95943492T 1994-07-20 1995-07-10 Faste lægemiddelformer, som indeholder clathrater af det steroide könshormon ethinylestadiol DK0771217T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4426709A DE4426709A1 (de) 1994-07-20 1994-07-20 Steroidale Sexualhormone enthaltende feste Arzneiformen
PCT/EP1995/002656 WO1996002277A1 (de) 1994-07-20 1995-07-10 Feste arzneiformen, enthaltend clathrate von steroidalen sexualhormonen

Publications (1)

Publication Number Publication Date
DK0771217T3 true DK0771217T3 (da) 2004-08-02

Family

ID=6524338

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95943492T DK0771217T3 (da) 1994-07-20 1995-07-10 Faste lægemiddelformer, som indeholder clathrater af det steroide könshormon ethinylestadiol

Country Status (11)

Country Link
US (1) US5798338A (da)
EP (1) EP0771217B1 (da)
JP (1) JPH10502912A (da)
AT (1) ATE263578T1 (da)
CA (1) CA2194979C (da)
DE (4) DE4426709A1 (da)
DK (1) DK0771217T3 (da)
ES (1) ES2218561T3 (da)
FR (1) FR07C0001I2 (da)
PT (1) PT771217E (da)
WO (1) WO1996002277A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652196A1 (de) * 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
EP1353699B1 (en) * 2000-12-20 2012-02-01 Bayer Pharma Aktiengesellschaft Beta-cyclodextrin-drospirenone inclusion complexes
EP1216712A1 (en) 2000-12-20 2002-06-26 Schering Aktiengesellschaft Cyclodextrin-drospirenone inclusion complexes
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
US20050020554A1 (en) * 2003-06-06 2005-01-27 Ahmed Salah U. Stability of hormone formulations
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
US20070287684A1 (en) * 2006-05-22 2007-12-13 Irshad Chaudry Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof
US8617597B2 (en) * 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN101489563A (zh) 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
KR20100117603A (ko) * 2008-02-13 2010-11-03 바이엘 쉐링 파마 악티엔게젤샤프트 안정화 효과를 갖는 약물 전달 시스템
WO2009101021A2 (en) * 2008-02-13 2009-08-20 Bayer Schering Pharma Aktiengesellschaft Estradiol-containing drug delivery system
WO2009132208A1 (en) * 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
EP2143432A1 (en) 2008-07-11 2010-01-13 Bayer Schering Pharma AG 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer
UY32836A (es) 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
CA2796139A1 (en) 2010-04-15 2011-10-20 Bayer Intellectual Property Gmbh Low-dosed solid oral dosage forms for hrt
CA2795801C (en) 2010-04-15 2018-05-29 Bayer Intellectual Property Gmbh Very low-dosed solid oral dosage forms for hrt
CN101869113B (zh) * 2010-06-17 2013-09-04 中国农业科学院植物保护研究所 一种鼠类不育剂的环糊精包合物及其制备方法
AU2011303475B2 (en) 2010-09-16 2016-07-14 Shimoda Biotech (Pty) Ltd Fulvestrant compositions and methods of use
WO2012120365A1 (en) 2011-03-07 2012-09-13 Aurobindo Pharma Limited Stable pharmaceutical composition comprising ethinyl estradiol
US9359451B2 (en) 2012-05-15 2016-06-07 The Uab Research Foundation Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof
PT3681475T (pt) 2017-10-16 2021-03-08 Faes Farma Sa Composições aquosas compreendendo bilastina e mometasona
EP3666260A1 (en) * 2018-12-13 2020-06-17 Laboratorios Leon Farma SA Ethinyl estradiol-beta-cyclodextrin complex and process for preparing thereof
CN114225050B (zh) * 2022-01-29 2022-12-13 国家卫生健康委科学技术研究所 炔雌醇环糊精复合物的制备及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57106698A (en) * 1980-12-22 1982-07-02 Kyowa Hakko Kogyo Co Ltd Easily absorbable map composition and preparation containing the same
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
JPH0764884B2 (ja) * 1986-11-27 1995-07-12 株式会社トクヤマ シクロデキストリン組成物
US4877774A (en) * 1987-09-09 1989-10-31 The United States Of America As Represented By The Department Of Health And Human Services Administration of steroid hormones

Also Published As

Publication number Publication date
ES2218561T3 (es) 2004-11-16
FR07C0001I1 (da) 2007-03-09
US5798338A (en) 1998-08-25
EP0771217A1 (de) 1997-05-07
CA2194979A1 (en) 1996-02-01
DE4426709A1 (de) 1996-01-25
FR07C0001I2 (da) 2009-01-02
WO1996002277A1 (de) 1996-02-01
JPH10502912A (ja) 1998-03-17
ATE263578T1 (de) 2004-04-15
DE122007000011I1 (de) 2007-05-10
EP0771217B1 (de) 2004-04-07
DE59510887D1 (de) 2004-05-13
PT771217E (pt) 2004-08-31
DE122007000013I1 (da) 2007-04-26
CA2194979C (en) 2009-01-06

Similar Documents

Publication Publication Date Title
DK0771217T3 (da) Faste lægemiddelformer, som indeholder clathrater af det steroide könshormon ethinylestadiol
DE59104432D1 (de) -g(a)-CYANACRYLATKLEBSTOFFZUSAMMENSETZUNGEN.
BR9908094A (pt) Preparado combinado de estrogênio e antiestrogênio
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
DK0868188T3 (da) Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen
DK0655916T3 (da) Middel til transdermal administration indeholdende 3-ketodesogestrel
DK0577602T3 (da) Transdermale antikonceptionelle formuleringer, fremgangsmåder og anordninger
WO1999012531A3 (de) Mittel zur hormonalen kontrazeption
ATE241990T1 (de) 3-beta-hydroxylierte natürliche steroidderivate enthaltende arzneimittelzusammensetzungen und ihre verwendung
IL166432A0 (en) Composition containing an androgenous 11?-halogen steroid and a progestational hormone and male contraceptive based on said composition
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
CA2294783A1 (fr) Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine
AU3651895A (en) Use of aromatase inhibitors for the production of a pharmaceutical agent for treating a relative androgen deficiency in men
AR073972A2 (es) Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas
WO2002019982A3 (en) Cosmetic composition and method for reducing or preventing wrinkling
TR200001288T2 (tr) Östrojen yoksunluğu sendromunun tedavisinde faydalı 2-arilbenzo (b) tiyofenler.
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
EP0810251A3 (en) Storage-stable one-component air activated formulations of polythiol and polyene employing iron compound
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
AU1962495A (en) Blocking unit for a fallopian tube
PL320198A1 (en) Children-safe active substance plaster package
HUP0300128A2 (en) Male contraceptive composition comprising norethisterone and its use
KR970061245A (ko) 프로제스테론 및 에스트로젠 작동약을 사용한, 뼈 손실 예방용 약학 조성물
HUP9902286A2 (hu) Javított gyógyászati készítmény szteroidvegyületek adagolására
CA2421302A1 (en) 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds